youtube_live
Q3 2026 earnings • released • EPS miss -11.37%
See resultschevron_right
SYRE:NASDAQ
Spyre Therapeutics Inc
$103.86
arrow_upward
+7.53%(+7.27) 1D
$103.00
arrow_downward
-0.83% (-0.86)bedtimeAfter hours
Closed: Nov 6, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SYRE...
Open
$98.35
High
$104.30
Low
$97.29
Mkt. cap
9.86B
Avg. vol.
1.28M
Volume
1.64M
52-wk high
$110.18
52-wk low
$21.14
EPS
-$3.22
Beta
3.24
Shares outstanding
94.97M
No. of employees
130
Open
$98.35
High
$104.30
Low
$97.29
Mkt. cap
9.86B
Avg. vol.
1.28M
Volume
1.64M
52-wk high
$110.18
52-wk low
$21.14
EPS
-$3.22
Beta
3.24
Shares outstanding
94.97M
No. of employees
130
News stories
From web sources and news partners
TradingView
·
1 day ago
H&S in a Falling Channel, Short Toward 7,000 for CAPITALCOM:SPX500 by Audacity618
BigGo Finance
·
2 hours ago
Global AI and Semiconductor Stocks Plunge; S&P 500 Tumbles 4.4% in a Single Day as Markets Watch Whether Three Central Banks Will Raise Rates in December
Quantisnow
·
9 hours ago
Consumer Staples sector performance - S&P 500 consumer staples stocks
www.tmgm.com
·
1 day ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
About Spyre Therapeutics Inc
CEO-
Employees130
FoundedJan 1, 2013
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitespyre.com